Filarial Excretory-Secretory Products Induce Human Monocytes to Produce Lymphangiogenic Mediators

PLoS Neglected Tropical Diseases

Volumn 8, Issue 7, 2014, Pages

  Weinkopff, Tiffany ^a,b   Mackenzie, Charles ^c,d   Eversole, Rob ^d   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MATRIGEL; PODOPLANIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; CYTOKINE; PARASITE ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL PRODUCT; ANIMAL TISSUE; ARTICLE; BRIGHT FIELD MICROSCOPY; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FILARIA; FILARIAL EXCRETORY PRODUCT; FILARIAL SECRETORY PRODUCT; FILARIASIS; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIMULUS LYSATE TEST; LYMPHANGIOGENESIS; LYMPHOCYTE; MALE; MERIONES UNGUICULATUS; MONOCYTE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE CONTRAST MICROSCOPY; RAT; VASCULARIZATION; ANIMAL; IMMUNOLOGY; LYMPHATIC FILARIASIS; METABOLISM; PARASITOLOGY; PHYSIOLOGY; WUCHERERIA BANCROFTI;

ANIMALS; ANTIGENS, HELMINTH; CYTOKINES; ELEPHANTIASIS, FILARIAL; HUMANS; MONOCYTES; WUCHERERIA BANCROFTI;

EID: 84905460417     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002893     Document Type: Article

References (57)

1. Tortora GJ, Grabowski SR, editors(2003) Principles of anatomy and physiology. 10th ed. New York: John Wiley & Sons. 512 p.
2. Ottesen EA, Duke BO, Karam M, Behbehani K, (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491-503.
3. Nutman TB, Kumaraswami V, (2001) Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol 23: 389-399.
4. Freedman DO, de Almeida Filho PJ, Besh S, Maia e Silva MC, Braga C, et al. (1994) Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 170: 927-933.
5. Freedman DO, de Almeido Filho PJ, Besh S, Maia e Silva MC, Braga C, et al. (1995) Abnormal lymphatic function in presymptomatic bancroftian filariasis. J Infect Dis 171: 997-1001.
6. Noroes J, Addiss D, Amaral F, Coutinho A, Medeiros Z, et al. (1996) Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg 90: 55-56.
7. Noroes J, Addiss D, Santos A, Medeiros Z, Coutinho A, et al. (1996) Ultrasonographic evidence of abnormal lymphatic vessels in young men with adult Wuchereria bancrofti infection in the scrotal area. J Urol 156: 409-412.
8. Amaral F, Dreyer G, Figueredo-Silva J, Noroes J, Cavalcanti A, et al. (1994) Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg 50: 753-757.
9. Dissanayake S, Watawana L, Piessens WF, (1995) Lymphatic pathology in Wuchereria bancrofti microfilaraemic infections. Trans R Soc Trop Med Hyg 89: 517-521.
10. Freedman DO, (1998) Immune dynamics in the pathogenesis of human lymphatic filariasis. Parasitol Today 14: 229-234.
11. Shenoy RK, Suma TK, Kumaraswami V, Dhananjayan G, Rahmah N, et al. (2008) Lymphoscintigraphic evidence of lymph vessel dilation in the limbs of children with Brugia malayi infection. J Commun Dis 40: 91-100.
12. Nelson FK, Greiner DL, Shultz LD, Rajan TV, (1991) The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med 173: 659-663.
13. Vincent AL, Vickery AC, Lotz MJ, Desai U, (1984) The lymphatic pathology of Brugia pahangi in nude (athymic) and thymic mice C3H/HeN. J Parasitol 70: 48-56.
14. Vickery AC, Albertine KH, Nayar JK, Kwa BH, (1991) Histopathology of Brugia malayi-infected nude mice after immune-reconstitution. Acta Trop 49: 45-55.
15. Vickery AC, Vincent AL, Sodeman WA Jr, (1983) Effect of immune reconstitution on resistance to Brugia pahangi in congenitally athymic nude mice. J Parasitol 69: 478-485.
16. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, et al. (2009) Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection. Ann Trop Med Parasitol 103: 235-247.
17. Adams RH, Alitalo K, (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
18. Al-Rawi MA, Watkins G, Mansel RE, Jiang WG, (2005) The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol 27: 721-730.
19. Brizzi MF, Garbarino G, Rossi PR, Pagliardi GL, Arduino C, et al. (1993) Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest 91: 2887-2892.
20. Choi I, Lee YS, Chung HK, Choi D, Ecoiffier T, et al. (2013) Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration. Angiogenesis 16: 29-44.
21. Dentelli P, Del Sorbo L, Rosso A, Molinar A, Garbarino G, et al. (1999) Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. J Immunol 163: 2151-2159.
22. Holzinger C, Weissinger E, Zuckermann A, Imhof M, Kink F, et al. (1993) Effects of interleukin-1,-2,-4,-6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. Immunol Lett 35: 109-117.
23. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, et al. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801.
24. Li A, Dubey S, Varney ML, Dave BJ, Singh RK, (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170: 3369-3376.
25. Yao JS, Zhai W, Young WL, Yang GY, (2006) Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 342: 1396-1404.
26. Lohela M, Bry M, Tammela T, Alitalo K, (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154-165.
27. Bennuru S, Maldarelli G, Kumaraswami V, Klion AD, Nutman TB, (2010) Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections. Am J Trop Med Hyg 83: 884-890.
28. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, et al. (2006) Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2: e92.
29. Debrah AY, Mand S, Toliat MR, Marfo-Debrekyei Y, Batsa L, et al. (2007) Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg 77: 601-608.
30. Mackenzie CD, Huntington MK, Wanji S, Lovato RV, Eversole RR, et al. (2010) The association of adult Onchocerca volvulus with lymphatic vessels. J Parasitol 96: 219-221.
31. Attout T, Hoerauf A, Denece G, Debrah AY, Marfo-Debrekyei Y, et al. (2009) Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule. PLoS One 4: e8234.
32. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115: 247-257.
33. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, et al. (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050.
34. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, et al. (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115: 2363-2372.
35. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, et al. (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947-956.
36. Zumsteg A, Christofori G, (2012) Myeloid cells and lymphangiogenesis. Cold Spring Harb Perspect Med 2: a006494.
37. Mackenzie CD, Muston JM, Elassad A, Nichols E, Eversole RR, et al. (2006) Host response to chitin and chitosan; reduced scaring and improved healing. The 7th Asia Pacific Chitin and Chitosan symposium, April 23-26, Busan, Korea: 514-516.
38. Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, et al. (2009) The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 183: 4705-4714.
39. Curtis AS, (1960) Area and volume measurements by random sampling methods. Med Biol Illus 10: 261-266.
40. Case T, Leis B, Witte M, Way D, Bernas M, et al. (1991) Vascular abnormalities in experimental and human lymphatic filariasis. Lymphology 24: 174-183.
41. Figueredo-Silva J, Noroes J, Cedenho A, Dreyer G, (2002) The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease. Ann Trop Med Parasitol 96: 531-541.
42. Vickery AC, Nayar JK, Albertine KH, (1985) Differential pathogenicity of Brugia malayi, B. patei and B. pahangi in immunodeficient nude mice. Acta Trop 42: 353-363.
43. Weinkopff T, Lammie P, (2011) Lack of evidence for the direct activation of endothelial cells by adult female and microfilarial excretory-secretory products. PLoS One 6: e22282.
44. Bennuru S, Nutman TB, (2009) Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis. PLoS Pathog 5: e1000688.
45. Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, et al. (2009) Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 284: 22364-22378.
46. Schroeder JH, Simbi BH, Ford L, Cole SR, Taylor MJ, et al. (2012) Live Brugia malayi microfilariae inhibit transendothelial migration of neutrophils and monocytes. PLoS Negl Trop Dis 6: e1914.
47. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, et al. (2001) A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98: 12677-12682.
48. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, et al. (2002) Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16: 1985-1987.
49. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, et al. (2003) VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 111: 717-725.
50. Angeli V, Randolph GJ, (2006) Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 4: 217-228.
51. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
52. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, et al. (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196: 1497-1506.
53. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92: 3566-3570.
54. O'Reilly S, Ciechomska M, Cant R, Hugle T, van Laar JM, (2012) Interleukin-6, its role in fibrosing conditions. Cytokine Growth Factor Rev 23: 99-107.
55. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099.
56. Hong YK, Shin JW, Detmar M, (2004) Development of the lymphatic vascular system: a mystery unravels. Dev Dyn 231: 462-473.
57. Wuest TR, Carr DJ, (2010) VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med 207: 101-115.